PL2983616T3 - Sposób i kompozycja do leczenia nieswoistego zapalenia jelit bez kolektomii - Google Patents

Sposób i kompozycja do leczenia nieswoistego zapalenia jelit bez kolektomii

Info

Publication number
PL2983616T3
PL2983616T3 PL14783373T PL14783373T PL2983616T3 PL 2983616 T3 PL2983616 T3 PL 2983616T3 PL 14783373 T PL14783373 T PL 14783373T PL 14783373 T PL14783373 T PL 14783373T PL 2983616 T3 PL2983616 T3 PL 2983616T3
Authority
PL
Poland
Prior art keywords
colectomy
composition
inflammatory bowel
bowel disease
treating inflammatory
Prior art date
Application number
PL14783373T
Other languages
English (en)
Inventor
Marc Ramer
Stephen F. Badylak
Timothy Keane
Original Assignee
Regentys Corp
Univ Pittsburgh Commonwealth Sys Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regentys Corp, Univ Pittsburgh Commonwealth Sys Higher Education filed Critical Regentys Corp
Publication of PL2983616T3 publication Critical patent/PL2983616T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32—Surgical cutting instruments
    • A61B17/3205—Excision instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3629—Intestinal tissue, e.g. small intestinal submucosa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3679—Hollow organs, e.g. bladder, esophagus, urether, uterus, intestine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Dispersion Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
PL14783373T 2013-04-08 2014-04-08 Sposób i kompozycja do leczenia nieswoistego zapalenia jelit bez kolektomii PL2983616T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361809606P 2013-04-08 2013-04-08
US201361843286P 2013-07-05 2013-07-05
US201361901237P 2013-11-07 2013-11-07
EP14783373.5A EP2983616B1 (en) 2013-04-08 2014-04-08 Method and composition for treating inflammatory bowel disease without colectomy
PCT/US2014/033365 WO2014168964A1 (en) 2013-04-08 2014-04-08 Method and composition for treating inflammatory bowel disease without colectomy

Publications (1)

Publication Number Publication Date
PL2983616T3 true PL2983616T3 (pl) 2019-05-31

Family

ID=51689961

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14783373T PL2983616T3 (pl) 2013-04-08 2014-04-08 Sposób i kompozycja do leczenia nieswoistego zapalenia jelit bez kolektomii

Country Status (14)

Country Link
US (2) US20160045552A1 (pl)
EP (1) EP2983616B1 (pl)
JP (1) JP6461096B2 (pl)
KR (1) KR102129562B1 (pl)
CN (1) CN105358095B (pl)
AU (2) AU2014251110A1 (pl)
CA (1) CA2907774C (pl)
DK (1) DK2983616T3 (pl)
ES (1) ES2703785T3 (pl)
HK (1) HK1221393A1 (pl)
HU (1) HUE042704T2 (pl)
IL (1) IL241910B (pl)
PL (1) PL2983616T3 (pl)
WO (1) WO2014168964A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106456837B (zh) 2014-03-21 2020-04-10 匹兹堡大学-联邦高等教育体系 最终消毒的来自细胞外基质的水凝胶的制备方法
US20160000550A1 (en) * 2014-07-05 2016-01-07 Deborah Nagle Methods for treating diseases of the colon
CA3017747A1 (en) 2016-03-14 2017-09-21 Regentys Corporation Method and composition for treating inflammatory bowel disease
EP3500193A4 (en) * 2016-08-19 2020-04-08 Regentys Corporation EXTRA-CELLULAR MATRIX FOR TISSUE CONSTRUCTION OF MUSCLE TISSUE
ES2931299T3 (es) 2017-03-02 2022-12-28 Univ Pittsburgh Commonwealth Sys Higher Education Hidrogel de matriz extracelular (ECM) y fracción soluble del mismo para su utilización en el tratamiento del cáncer
US11213545B2 (en) 2017-03-02 2022-01-04 University of Pittsburgh—of the Commonwealth System of Higher Education ECM hydrogel for treating esophageal inflammation
AU2018204259B2 (en) * 2017-06-29 2019-08-15 Covidien Lp Systems and methods for ablative treatment of irritable bowel disease
WO2019217812A1 (en) 2018-05-11 2019-11-14 Boston Scientific Scimed, Inc. Devices, systems, and methods for tissue resection
EP3810213A4 (en) * 2018-06-21 2022-03-23 University of Pittsburgh - of the Commonwealth System of Higher Education USE OF URINARY BLADDER ECM HYDROGEL AS AN ESOPHAGIC SUBMUCOSAL FLUID CUSHION
ES2966711T3 (es) * 2018-06-21 2024-04-23 Univ Pittsburgh Commonwealth Sys Higher Education Hidrogel de matriz extracelular (ECM) como almohadilla líquida submucosa
US20210244855A1 (en) * 2018-06-21 2021-08-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of an extracellular matrix (ecm) hydrogel as an esophageal submucosal fluid cushion

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
US5275826A (en) * 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US6974796B1 (en) * 1999-08-17 2005-12-13 Girsh Leonard S Therapeutic compositions for treatment of a damaged tissue
US5554389A (en) 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
US5711969A (en) * 1995-04-07 1998-01-27 Purdue Research Foundation Large area submucosal tissue graft constructs
SE9602644D0 (sv) * 1996-07-04 1996-07-04 Astra Ab New use
US6576265B1 (en) * 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
CA2536923C (en) * 2003-09-04 2012-10-09 Cook Biotech Incorporated Extracellular matrix composite materials, and manufacture and use thereof
EP1876965B1 (en) * 2005-04-29 2018-09-12 Cook Biotech, Inc. Volumetric grafts for treatment of fistulae and related systems
GB2447400B (en) * 2006-01-31 2011-11-02 Cook Biotech Inc Fistula grafts and related methods and systems for treating fistulae
US8084023B2 (en) 2007-01-22 2011-12-27 The Board Of Trustees Of The University Of Arkansas Maintenance and propagation of mesenchymal stem cells
EP2121061A2 (en) * 2007-03-07 2009-11-25 Coloplast A/S Mesh comprising ecm
EP2022848A1 (en) * 2007-08-10 2009-02-11 Hubrecht Institut A method for identifying, expanding, and removing adult stem cells and cancer stem cells
US8614296B2 (en) * 2008-04-24 2013-12-24 Gene Techno Science Co., Ltd. Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof
AU2009259828B2 (en) * 2008-06-20 2014-05-08 Cook Biotech Incorporated Compressible/expandable medical graft products, and methods for applying hemostasis
US8415159B2 (en) * 2008-07-30 2013-04-09 Mesynthes Ltd. Tissue scaffolds derived from forestomach extracellular matrix
CN101366976B (zh) * 2008-09-03 2012-08-29 陕西瑞盛生物科技有限公司 人源化异种细胞外基质材料及其制备方法
BRPI1008628A2 (pt) * 2009-02-18 2016-03-01 Cormatrix Cardiovascular Inc método de tratamento ou prevenção de arritmia cardíaca em um indivíduo
BR112012000114A2 (pt) * 2009-07-06 2016-11-01 Coloplast As arcabouço biodegradável para regeneração de tecido mole e uso do mesmo
KR101809761B1 (ko) * 2009-09-24 2017-12-15 가부시키가이샤 진 테크노 사이언스 세포 외 기질 단백질의 아미노산 서열 ｒｇｄ에 특이적인 인간화된 항체 및 그의 용도
WO2011044443A2 (en) * 2009-10-09 2011-04-14 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Matricryptic ecm peptides for tissue reconstruction
WO2012002986A2 (en) * 2009-12-21 2012-01-05 The Regents Of The University Of California Decellularized and delipidized extracellular matrix and methods of use
JP2011246461A (ja) * 2010-04-27 2011-12-08 Mitsubishi Tanabe Pharma Corp 新規アミド誘導体を含有する医薬組成物
WO2011150055A2 (en) * 2010-05-25 2011-12-01 Cook Biotech Incorporated Methods, substrates, and systems useful for cell seeding of medical grafts
ES2791312T3 (es) * 2010-07-02 2020-11-03 Univ North Carolina Chapel Hill Andamios de biomatriz para la dispersión a escala industrial
US9938502B2 (en) * 2010-11-10 2018-04-10 Wake Forest University Health Sciences Tissue-specific extracellular matrix with or without tissue protein components for cell culture
CN102552910B (zh) * 2010-12-31 2014-06-04 中国科学院上海生命科学研究院 细胞外基质蛋白1及其调节剂在制备过敏性疾病诊断或治疗药物中的应用
CA2862611C (en) * 2011-02-24 2020-11-03 Eximo Medical Ltd. Hybrid catheter for tissue resection
JP6552115B2 (ja) * 2013-03-15 2019-07-31 クック・メディカル・テクノロジーズ・リミテッド・ライアビリティ・カンパニーＣｏｏｋ Ｍｅｄｉｃａｌ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｌｃ 消化管病変を治療するための接着性医療製品及び方法

Also Published As

Publication number Publication date
KR20160016778A (ko) 2016-02-15
AU2014251110A1 (en) 2015-11-26
JP6461096B2 (ja) 2019-01-30
CA2907774C (en) 2022-11-01
CA2907774A1 (en) 2014-10-16
AU2019203323A1 (en) 2019-05-30
HUE042704T2 (hu) 2019-07-29
EP2983616A4 (en) 2016-08-31
JP2016520560A (ja) 2016-07-14
CN105358095B (zh) 2020-11-20
CN105358095A (zh) 2016-02-24
US20160045552A1 (en) 2016-02-18
EP2983616B1 (en) 2018-10-03
WO2014168964A1 (en) 2014-10-16
AU2019203323B2 (en) 2020-10-08
DK2983616T3 (en) 2019-01-21
US20170112964A1 (en) 2017-04-27
ES2703785T3 (es) 2019-03-12
EP2983616A1 (en) 2016-02-17
IL241910B (en) 2021-04-29
KR102129562B1 (ko) 2020-07-03
HK1221393A1 (zh) 2017-06-02

Similar Documents

Publication Publication Date Title
HK1221393A1 (zh) 不用結腸切除術治療炎性腸病的方法和組合物
IL245281A0 (en) Methods and preparations for the treatment of cancer
HK1219512A1 (zh) 用於診斷和治療炎性腸病的方法
HK1221422A1 (zh) 診斷方法和用於治療成膠質細胞瘤的組合物
SG10201707319UA (en) Compositions and methods for treating mpsi
EP2942703A4 (en) METHOD AND APPARATUS FOR APPLICATION SHARING
EP2958936A4 (en) METHOD AND COMPOSITIONS FOR TREATING CORI DISEASE
IL243928A0 (en) Preparations and methods for the treatment of complementary related conditions
PL3238707T3 (pl) Kompozycje i sposoby leczenia nadmiernej przepuszczalności jelit
HK1217650A1 (zh) 用於治療劇痛的組合物及方法
IL261738A (en) Method and composition for treating inflammatory bowel disease
HK1215373A1 (zh) 用於治療代謝疾病的方法和裝置
GB201305414D0 (en) Method and composition
HK1224184A1 (zh) 用於治療炎性疾病的化合物、藥物組合物和方法
IL245602A0 (en) Compositions and methods for evaluating intestinal function
PL3084506T3 (pl) Endoskop i sposób jego użycia
HK1225647A1 (zh) 用於治療癌症的組合物和方法
ZA201505875B (en) Compositions and methods for treating and repairing tendons
EP2968377A4 (en) COMPOSITIONS AND METHODS OF TREATING INFECTION DISEASES
GB201315846D0 (en) Method for treating or preventing hot flushes
SG10201710538XA (en) Compositions and methods for treating skin
IL245703A0 (en) Methods and preparations for the treatment of amyloid deposits
EP2970510A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES
HK1218249A1 (zh) 用於治療炎症性腸道疾病的化合物和方法
EP2968505A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTOIMMUNE DISEASES